Nucleic acids encoding plant glutamine phenylpyruvate transaminase (GPT) and uses thereof
View Patent ↗Glutamine phenylpyruvate transaminase (GPT) proteins, nucleic acid molecules encoding GPT proteins, and uses thereof are disclosed. Provided herein are various GPT proteins and GPT gene coding sequences isolated from a number of plant species. As disclosed herein, GPT proteins share remarkable structural similarity within plant species, and are active in catalyzing the synthesis of 2-hydroxy-5-oxoproline (2-oxoglutaramate), a powerful signal metabolite which regulates the function of a large number of genes involved in the photosynthesis apparatus, carbon fixation and nitrogen metabolism.
1. A nucleic acid construct comprising a heterologous plant promoter operably linked to an isolated polynucleotide having a sequence selected from the group consisting of (a) the nucleotide sequence of SEQ ID NO: 45; (b) a nucleotide sequence having at least 90% identity to SEQ ID NO: 45, and encoding a polypeptide having glutamine phenylpyruvate transaminase (GPT) activity; (c) a nucleotide sequence encoding the polypeptide of SEQ ID NO: 46, or a polypeptide having at least 90% sequence identity thereto which has GPT activity; and, (d) a nucleotide sequence encoding the polypeptide of SEQ ID NO: 46 truncated at its amino terminus by between 30 to 56 amino acid residues, or a polypeptide having at least 90% sequence identity thereto which has GPT activity.
2. The nucleic acid construct of claim 1 comprising the nucleotide sequence of SEQ ID NO: 45 or the nucleotide sequence which encodes a polypeptide of SEQ ID NO: 46.
3. The nucleic acid construct according to claim 1 , wherein the heterologous promoter is a tissue-specific promoter.
4. A vector comprising the nucleic acid construct of claim 1 .
5. A host cell comprising the nucleic acid construct of claim 1 , or comprising a vector which comprises the nucleic acid construct of claim 1 .
6. The host cell of claim 5 , which is a plant cell.
7. The plant cell of claim 6 , wherein the plant cell expresses the polynucleotide.
8. A plant organ, embryo or seed comprising the nucleic acid construct according to claim 1 , wherein the plant organ, embryo or seed expresses the polynucleotide.
9. A transgenic plant comprising the nucleic acid construct of claim 1 , or comprising a vector which comprises the nucleic acid construct of claim 1 , wherein the transgenic plant expresses the polynucleotide.
10. A progeny of the transgenic plant according to claim 9 , wherein the progeny comprises the nucleic acid construct of claim 1 .
11. A nucleic acid construct comprising a heterologous plant promoter operably linked to an isolated polynucleotide having a nucleic acid sequence which is fully complementary to the isolated polynucleotide of claim 1 .
12. A seed of any generation of the transgenic plant of claim 9 or a seed of a progeny of the transgenic plant according to claim 9 , wherein the progeny comprises the nucleic acid construct of claim 1 .
13. A plant of any generation of the seed of claim 12 , wherein said plant comprises the nucleic acid construct of claim 1 .
14. The plant cell of claim 7 , wherein the plant cell has higher GPT activity in comparison to an analogous plant cell of a wild-type or untransformed plant.
15. The plant cell of claim 7 , wherein the plant cell has a higher concentration of 2-oxoglutaramate in comparison to an analogous plant cell of a wild-type or untransformed plant.
16. The plant organ, embryo or seed of claim 8 , wherein the plant organ, embryo or seed has higher GPT activity in comparison to an analogous plant organ, embryo or seed of a wild-type or untransformed plant.
17. The plant organ, embryo or seed of claim 8 , wherein the plant organ, embryo or seed has a higher concentration of 2-oxoglutaramate in comparison to an analogous plant organ, embryo or seed of a wild-type or untransformed plant.
18. The transgenic plant of claim 9 , wherein the transgenic plant has higher GPT activity in comparison to an analogous wild-type or untransformed plant.
19. The transgenic plant of claim 9 , wherein the transgenic plant has a higher concentration of 2-oxoglutaramate in comparison to an analogous wild-type or untransformed plant.
20. The transgenic plant of claim 9 , wherein the transgenic plant displays increased biomass yield when compared to an analogous wild-type or untransformed plant.
21. The transgenic plant of claim 9 , wherein the transgenic plant has at least one increased growth characteristic selected from the group consisting of increased biomass, earlier flowering, earlier budding, increased plant height, increased flowering, increased budding, larger leaves, increased fruit or pod yield, and increased seed yield.
22. The transgenic plant of claim 9 , wherein the transgenic plant has an increased leaf-to-root ratio of glutamine synthetase activity in comparison to an analogous wild-type or untransformed plant.
23. The nucleic acid construct according to claim 1 , wherein the heterologous promoter is a constitutive promoter.